Santos Emilie M M, Arrarte Terreros Nerea, Kappelhof Manon, Borst Jordi, Boers Anna M M, Lingsma Hester F, Berkhemer Olvert A, Dippel Diederik W J, Majoie Charles B, Marquering Henk A, Niessen Wiro J
Department of Radiology and Nuclear Medicine, Amsterdam UMC, Amsterdam, the Netherlands; Department of Biomedical Engineering and Physics, Amsterdam UMC, Amsterdam, the Netherlands; Department of Radiology and Nuclear Medicine, Erasmus Universtiy Medical Center, Rotterdam, the Netherlands; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.
Department of Radiology and Nuclear Medicine, Amsterdam UMC, Amsterdam, the Netherlands; Department of Biomedical Engineering and Physics, Amsterdam UMC, Amsterdam, the Netherlands.
J Biomech. 2021 Nov 9;128:110700. doi: 10.1016/j.jbiomech.2021.110700. Epub 2021 Aug 28.
Thrombus perviousness is strongly associated with functional outcome and intravenous alteplase treatment success in patients with acute ischemic stroke. Accuracy of thrombus attenuation increase (TAI) assessment may be compromised by a heterogeneous thrombus composition and interobserver variations of currently used manual measurements. We hypothesized that TAI is more strongly associated with clinical outcomes when evaluated on the entire thrombus. In 195 patients, five TAI measures were performed: one manual by placing three regions of interest (TAI) and four automated ones assessing densities from the entire thrombus. The automated TAI measures were calculated by comparing quartiles; Q1, Q2, and Q3 of the non-contrast and contrast enhanced thrombus density distribution and using the lag of the maximum of the cross correlations (MCC). Associations with functional outcome (mRS at 90 days) were assessed with univariate and multivariable analyses. All entire TAI measures were significantly associated with functional outcome with odd ratios (OR) of 1.63(95 %CI:1.19-2.25, p = 0.003) for Q1, 1.56(95 %CI:1.16-2.10, p = 0.003) for Q2, 1.24(95 %CI:1.00-1.54, p = 0.045) for Q3, and 1.70(95 %CI:1.24-2.34, p = 0.001) for MCC per 10 HU increase in univariate models. TAI was not significantly associated with functional outcome (p = 0.055). In the multivariable logistic regression models including age, NIHSS, and recanalization, only TAI measures derived from the entire thrombus were independently associated with favorable outcome; OR of 1.64(95 %CI:1.01-2.66, p = 0.048) for Q2 and 1.82(1.13-2.95, p = 0.014) for MCC per 10 HU increase of thrombus attenuation. The novel perviousness measures of the entire thrombus are more strongly associated with functional outcome than the traditional manual perviousness assessments.
在急性缺血性中风患者中,血栓通透性与功能预后及静脉注射阿替普酶治疗的成功率密切相关。目前使用的手动测量方法存在观察者间差异,且血栓成分不均一,可能会影响血栓衰减增加(TAI)评估的准确性。我们假设,对整个血栓进行评估时,TAI与临床结局的关联更为紧密。对195例患者进行了五项TAI测量:一项是通过设置三个感兴趣区域进行手动测量(TAI),另外四项是对整个血栓密度进行自动测量。自动TAI测量是通过比较四分位数来计算的;即非增强和增强造影剂后血栓密度分布的Q1、Q2和Q3,并使用互相关最大值(MCC)的滞后值。通过单变量和多变量分析评估与功能预后(90天时的改良Rankin量表评分)的相关性。在单变量模型中,每增加10 HU,所有基于整个血栓的TAI测量值与功能预后均显著相关,Q1的比值比(OR)为1.63(95%CI:1.19 - 2.25,p = 0.003),Q2为1.56(95%CI:1.16 - 2.10,p = 0.003),Q3为1.24(95%CI:1.00 - 1.54,p = 0.045),MCC为1.70(95%CI:1.24 - 2.34,p = 0.001)。手动TAI测量与功能预后无显著相关性(p = 0.055)。在包含年龄、美国国立卫生研究院卒中量表(NIHSS)和再通情况的多变量逻辑回归模型中,只有基于整个血栓得出的TAI测量值与良好预后独立相关;每增加10 HU血栓衰减,Q2的OR为1.64(95%CI:1.01 - 2.66,p = 0.048),MCC为1.82(1.13 - 2.95,p = 0.014)。与传统的手动通透性评估相比,基于整个血栓的新型通透性测量与功能预后的关联更为紧密。